Artal Group’s Translate Bio, Inc. Common Stock TBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-500,000
| Closed | -$13.8M | – | 160 |
|
2021
Q2 | $13.8M | Sell |
500,000
-500,000
| -50% | -$13.8M | 0.28% | 68 |
|
2021
Q1 | $16.5M | Sell |
1,000,000
-200,000
| -17% | -$3.3M | 0.29% | 65 |
|
2020
Q4 | $22.1M | Sell |
1,200,000
-200,000
| -14% | -$3.69M | 0.47% | 49 |
|
2020
Q3 | $19.1M | Sell |
1,400,000
-200,000
| -13% | -$2.72M | 0.46% | 37 |
|
2020
Q2 | $28.7M | Buy |
1,600,000
+1,000,000
| +167% | +$17.9M | 0.8% | 28 |
|
2020
Q1 | $5.98M | Sell |
600,000
-50,000
| -8% | -$499K | 0.25% | 59 |
|
2019
Q4 | $5.29M | Sell |
650,000
-100,000
| -13% | -$814K | 0.2% | 61 |
|
2019
Q3 | $7.43M | Hold |
750,000
| – | – | 0.3% | 50 |
|
2019
Q2 | $9.47M | Buy |
750,000
+150,000
| +25% | +$1.89M | 0.38% | 45 |
|
2019
Q1 | $6.11M | Hold |
600,000
| – | – | 0.25% | 55 |
|
2018
Q4 | $4.5M | Hold |
600,000
| – | – | 0.17% | 47 |
|
2018
Q3 | $6M | Buy |
600,000
+100,000
| +20% | +$1M | 0.16% | 49 |
|
2018
Q2 | $6.33M | Buy |
+500,000
| New | +$6.33M | 0.13% | 43 |
|